Lindnera (Pichia) fabianii blood infection after mesenteric ischemia

Medical Mycology

Volumn 50, Issue 3, 2012, Pages 310-314

  Gabriel, Frederic ^a,b,c   Noel, Thierry ^a,b   Accoceberry, Isabelle ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b University Victor Segalen   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Blood infection; DNA barcoding; EF1alpha; Internal transcribed spacer (ITS) region; Lindnera (Pichia) fabianii

Indexed keywords

ALPRAZOLAM; AMIKACIN; C REACTIVE PROTEIN; CASPOFUNGIN; CIPROFLOXACIN; DNA 18S; ELONGATION FACTOR 1ALPHA; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 2; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; ZOPICLONE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOODSTREAM INFECTION; CASE REPORT; DNA BARCODING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FECES CULTURE; FEMALE; FEVER; FUNGAL STRAIN; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; INTUBATION; ISCHEMIA; MESENTERY BLOOD VESSEL; MYCOSIS; NUCLEOTIDE SEQUENCE; OROPHARYNX; PARAPLEGIA; PICHIA; RHABDOMYOLYSIS; SEQUENCE ANALYSIS; SUICIDE ATTEMPT; THROAT CULTURE; URINALYSIS;

ACUTE KIDNEY INJURY; ANTIFUNGAL AGENTS; BLOOD; DNA, FUNGAL; DNA, RIBOSOMAL; ECHINOCANDINS; FEMALE; FUNGEMIA; GENES, RRNA; HUMANS; ISCHEMIA; MIDDLE AGED; RNA, FUNGAL; RNA, RIBOSOMAL, 18S; SACCHAROMYCETALES; SEQUENCE ANALYSIS, DNA; SUICIDE; TREATMENT OUTCOME; VASCULAR DISEASES;

CANDIDA FABIANII; PICHIA;

EID: 84858379719     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.587455     Document Type: Article

References (30)

1. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419-4431. (Pubitemid 39362350)
2. Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011; 11: 142-151.
3. Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009). Diagn Microbiol Infect Dis 2010; 68: 278-283.
4. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 2010; 14: e954-966.
5. Kurtzman CP, Fell JW (eds). The Yeasts, a Taxonomic Study. Amsterdam: Elsevier, 1998.
6. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702 (Pubitemid 37345347)
7. Bougnoux ME, Gueho E, Potocka AC. Resolutive Candida utilis fungemia in a nonneutropenic patient. J Clin Microbiol 1993; 31: 1644-1645. (Pubitemid 23164440)
8. Kurtzman CP, Robnett CJ, Basehoar-Powers E. Phylogenetic relationships among species of Pichia, Issatchenkia and Williopsis determined from multigene sequence analysis, and the proposal of Barnettozyma gen. nov., Lindnera gen. nov. and Wickerhamomyces gen. nov. FEMS Yeast Res 2008; 8: 939-954.
9. Bhally HS, Jain S, Shields C, et al. Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med Mycol 2006; 44: 185-187. (Pubitemid 43135546)
10. Grenouillet F, Millon L, Chamouine A, et al. Pichia fabianii fungemia in a neonate. Pediatr Infect Dis J 2010; 29: 191.
11. Hamal P, Ostransky J, Dendis M, et al. A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment. Med Mycol 2008; 46: 601-605.
12. Valenza G, Valenza R, Brederlau J, Frosch M, Kurzai O. Identification of Candida fabianii as a cause of lethal septicaemia. Mycoses 2006; 49: 331-334. (Pubitemid 43894058)
13. León C, Álvarez-Lerma F, Ruiz-Santana S, et al. Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 2009; 28: 233-242.
14. Leroy O, Gangneux J, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37: 1612-1618.
15. Concia E, Azzini AM, Conti M. Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs 2009; 69 (Suppl. 1): 5-14.
16. Sganga G. Clinical aspects of invasive candidiasis in the surgical patient. Drugs 2009; 69 (Suppl. 1): 29-32.
17. Magill SS, Swoboda SMR, Shields CEB, et al. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. Ann Surg 2009; 249: 657-665.
18. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for can-didal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001; 33: 177-186. (Pubitemid 32643332)
19. Mavor AL, Thewes S, Hube B. Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets 2005; 6: 863-874. (Pubitemid 41672448)
20. Dooley DP, Beckius ML, McAllister CK, Jeffery BS. Prostatitis caused by Hansenula fabianii. J Infect Dis 1990; 161: 1040-1041. (Pubitemid 20148355)
21. Ciardo DE, Schär G, Böttger EC, Altwegg M, Bosshard PP. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J Clin Microbiol 2006; 44: 77-84. (Pubitemid 43100583)
22. Cendejas-Bueno E, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Identification of pathogenic rare yeast species in clinical samples: comparison between phenotypical and molecular methods. J Clin Microbiol 2010; 48: 1895-1899.
23. Gabriel F, Noel T, Accoceberry I. Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma. Med Mycol 2011; 49: 306-310.
24. Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5 ' end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216-1223. (Pubitemid 27175254)
25. Iwen PC, Hinrichs SH, Rupp ME. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol 2002; 40: 87-109. (Pubitemid 34168312)
26. Chen YC, Eisner JD, Kattar MM, et al. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J Clin Microbiol 2000; 38: 2302-2310. (Pubitemid 30414355)
27. Chen YC, Eisner JD, Kattar MM, et al. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol 2001; 39: 4042-4051. (Pubitemid 33029781)
28. Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 2002; 40: 1826-1830. (Pubitemid 34493167)
29. Nilsson RH, Kristiansson E, Ryberg M, Hallenberg N, Larsson K. Intraspecific ITS variability in the kingdom Fungi as expressed in the international sequence databases and its implications for molecular species identification. Evol Bioinform Online 2008; 4: 193-201. (Pubitemid 351865649)
30. Park B, Park J, Cheong K, et al. Cyber infrastructure for Fusarium: three integrated platforms supporting strain identification, phyloge-netics, comparative genomics and knowledge sharing. Nucleic Acids Res 2011; 39: D640-646.